VIPR2 antibody (AA 334-393)
Quick Overview for VIPR2 antibody (AA 334-393) (ABIN1886376)
Target
See all VIPR2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 334-393
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 334 and 393 of Human VIPR2
-
-
-
-
Application Notes
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Alternative Name
- VPAC2
-
Background
-
Vasoactive intestinal peptide (VIP, MIM 192320) and pituitary adenylate cyclase activating polypeptide (PACAP, MIM 102980) are homologous peptides that function as neurotransmitters and neuroendocrine hormones.While the receptors for VIP and PACAP share homology, they differ in their substrate specificities and expression patterns.See VIPR1 (MIM 192321) and ADCYAP1R1(MIM 102981).[supplied by OMIM]
-
Molecular Weight
- 49 kDa
-
Gene ID
- 7434
-
NCBI Accession
- NP_003373, NM_003382
-
Pathways
- cAMP Metabolic Process
Target
-